Literature DB >> 2825752

Lung cancer and prior tuberculosis infection in Shanghai.

W Zheng1, W J Blot, M L Liao, Z X Wang, L I Levin, J J Zhao, J F Fraumeni, Y T Gao.   

Abstract

In a population-based case-control study of lung cancer in Shanghai involving interviews during 1984-86 with 1,405 cancer patients and 1,495 controls, a significant 50% elevation in the risk of lung cancer, adjusted for cigarette smoking, was observed among persons who had a history of tuberculosis. Among those diagnosed with tuberculosis within the past 20 years, the risk exceeded 2.5-fold. In males the lung cancers tended to occur on the same side as the previous tuberculosis infection. For both sexes, the effect of recent tuberculosis was most apparent for adenocarcinoma and peripheral tumours. No relationship was found between lung cancer risk and the type of tuberculosis therapy, including use of isoniazid. The findings suggest that tuberculosis may predispose to lung cancer, with the association most apparent among recent survivors of the infection.

Entities:  

Mesh:

Year:  1987        PMID: 2825752      PMCID: PMC2001820          DOI: 10.1038/bjc.1987.233

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Scar cancer of the lung: increase over a 21 year period.

Authors:  O Auerbach; L Garfinkel; V R Parks
Journal:  Cancer       Date:  1979-02       Impact factor: 6.860

2.  Pulmonary tuberculosis, isoniazid and cancer.

Authors:  A H Campbell; P Guilfoyle
Journal:  Br J Dis Chest       Date:  1970-07

3.  Pulmonary tuberculosis and carcinoma of the lung. A survey from two population-based disease registers.

Authors:  R Steinitz
Journal:  Am Rev Respir Dis       Date:  1965-11

4.  Is isonicotinic acid hydrazide (INH) carcinogenic to man? A 24-year follow-up of 3371 tuberculosis cases.

Authors:  J Clemmesen; S Hjalgrim-Jensen
Journal:  Ecotoxicol Environ Saf       Date:  1979-12       Impact factor: 6.291

5.  Isoniazid therapy in relation to later occurrence of cancer in adults and in infants.

Authors:  E C Hammond; I J Selikoff; E H Robitzek
Journal:  Br Med J       Date:  1967-06-24

6.  An analysis of some risk factors for lung cancer in Hong Kong.

Authors:  L C Koo; J H Ho; N Lee
Journal:  Int J Cancer       Date:  1985-02-15       Impact factor: 7.396

7.  Late effects following isoniazid therapy.

Authors:  J D Boice; J F Fraumeni
Journal:  Am J Public Health       Date:  1980-09       Impact factor: 9.308

8.  Tuberculosis and lung cancer risk in nonsmoking women.

Authors:  M W Hinds; H I Cohen; L N Kolonel
Journal:  Am Rev Respir Dis       Date:  1982-06

Review 9.  Diet and lung cancer. A review of the epidemiologic evidence in humans.

Authors:  G A Colditz; M J Stampfer; W C Willett
Journal:  Arch Intern Med       Date:  1987-01

10.  Pulmonary scar carcinoma. A clinicopathologic analysis.

Authors:  G L Bakris; G P Mulopulos; R Korchik; E Z Ezdinli; J Ro; B H Yoon
Journal:  Cancer       Date:  1983-08-01       Impact factor: 6.860

View more
  22 in total

Review 1.  Lung cancer in never smokers: clinical epidemiology and environmental risk factors.

Authors:  Jonathan M Samet; Erika Avila-Tang; Paolo Boffetta; Lindsay M Hannan; Susan Olivo-Marston; Michael J Thun; Charles M Rudin
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

Review 2.  Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer.

Authors:  Peter N Lee; Barbara A Forey; Katharine J Coombs
Journal:  BMC Cancer       Date:  2012-09-03       Impact factor: 4.430

3.  Lower risk of lung cancer after multiple pneumonia diagnoses.

Authors:  Jill Koshiol; Melissa Rotunno; Dario Consonni; Angela Cecilia Pesatori; Sara De Matteis; Alisa M Goldstein; Anil K Chaturvedi; Sholom Wacholder; Maria Teresa Landi; Jay H Lubin; Neil E Caporaso
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-03       Impact factor: 4.254

4.  Tuberculosis and subsequent risk of lung cancer in Xuanwei, China.

Authors:  Eric A Engels; Min Shen; Robert S Chapman; Ruth M Pfeiffer; Ying-Ying Yu; Xingzhou He; Qing Lan
Journal:  Int J Cancer       Date:  2009-03-01       Impact factor: 7.396

5.  Is natural infection with M. tuberculosis protective against cancer?

Authors:  A Fragoulia; X G Kondakis; I Dimopoulos
Journal:  Eur J Epidemiol       Date:  1989-06       Impact factor: 8.082

6.  MAGE A1-A6 RT-PCR and MAGE A3 and p16 methylation analysis in induced sputum from patients with lung cancer and non-malignant lung diseases.

Authors:  Kyeong-Cheol Shin; Kwan-Ho Lee; Chae-Hun Lee; Im-Hee Shin; Hun-Suk Suh; Chang-Ho Jeon
Journal:  Oncol Rep       Date:  2011-11-29       Impact factor: 3.906

7.  Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors.

Authors:  Darren R Brenner; Rayjean J Hung; Ming-Sound Tsao; Frances A Shepherd; Michael R Johnston; Steven Narod; Warren Rubenstein; John R McLaughlin
Journal:  BMC Cancer       Date:  2010-06-14       Impact factor: 4.430

Review 8.  Previous lung diseases and lung cancer risk: a systematic review and meta-analysis.

Authors:  Darren R Brenner; John R McLaughlin; Rayjean J Hung
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

9.  Lung cancer among women in north-east China.

Authors:  A H Wu-Williams; X D Dai; W Blot; Z Y Xu; X W Sun; H P Xiao; B J Stone; S F Yu; Y P Feng; A G Ershow
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

10.  Identification of Key Genes and Pathways in Gefitinib-Resistant Lung Adenocarcinoma using Bioinformatics Analysis.

Authors:  Kailin Mao; Fang Lin; Yingai Zhang; Hailong Zhou
Journal:  Evol Bioinform Online       Date:  2021-06-11       Impact factor: 1.625

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.